I am the Chief Physicist at our regional site in Basking Ridge, New Jersey. I am responsible for all radiation physics activities at this site, including quality assurance, radiation calibration, treatment planning, development of treatment protocols, implementation of advanced treatment techniques, and clinical physics consultations.
My current research interest is in dosimetry for advanced delivery techniques. I have published more than 80 peer-reviewed articles and book chapters, and am the lead author for a large number of these. I have served in numerous task groups, work groups, and committees in both the American Association of Physicists in Medicine (AAPM) and American Society for Radiation Oncology (ASTRO) including Chair of the Subcommittee of Practice Guidelines of AAPM and member of the Guidelines Subcommittee of ASTRO.
I received a PhD in Medical Physics from the Medical College of Ohio in 1995 and was certified by the American Board of Medical Physics and the American Board of Radiology. I joined the faculty of Memorial Sloan Kettering in 1999.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Maria F. Chan discloses the following relationships and financial interests:
American College of Radiology
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.